Lab support for a global pediatric trial for the rare neuromuscular disease, Myotubular Myopathy. Cerba Research provides safety testing, PBMC isolation, biomarkers, and sample management for the clinical trial. Read more on the challenges and solutions in the case study.
Case Study – Pediatric Phase I/II/III Study in X-Linked Myotubular Myopathy (XLMTM)
Reach out to our experts and discover how we can help you advance your clinical trialContact Us